Inga Zerr

26.1k total citations · 2 hit papers
356 papers, 13.3k citations indexed

About

Inga Zerr is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Inga Zerr has authored 356 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 300 papers in Molecular Biology, 127 papers in Neurology and 102 papers in Neurology. Recurrent topics in Inga Zerr's work include Prion Diseases and Protein Misfolding (264 papers), Neurological diseases and metabolism (107 papers) and Alzheimer's disease research and treatments (73 papers). Inga Zerr is often cited by papers focused on Prion Diseases and Protein Misfolding (264 papers), Neurological diseases and metabolism (107 papers) and Alzheimer's disease research and treatments (73 papers). Inga Zerr collaborates with scholars based in Germany, Spain and United Kingdom. Inga Zerr's co-authors include S. Poser, Walter Schulz‐Schaeffer, Hans A. Kretzschmar, Matthias Schmitz, Otto Windl, Monika Bodemer, Thomas Weber, Franc Llorens, Saima Zafar and Armin Giese and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Inga Zerr

344 papers receiving 13.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects

1999 1.0k citations Piero Parchi, Sabina Capellari et al. profile →
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease

2021 171 citations Péter Hermann, Michael D. Geschwind et al. profile →

Peers

Countries citing papers authored by Inga Zerr

Since Specialization

Citations

This map shows the geographic impact of Inga Zerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Zerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Zerr more than expected).

Fields of papers citing papers by Inga Zerr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inga Zerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Zerr. The network helps show where Inga Zerr may publish in the future.

Co-authorship network of co-authors of Inga Zerr

This figure shows the co-authorship network connecting the top 25 collaborators of Inga Zerr. A scholar is included among the top collaborators of Inga Zerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inga Zerr. Inga Zerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alpha‐Synuclein Demonstrates Varying Binding Affinities With Different Tau Isoforms 2025 ·Journal of Neurochemistry ·(unknown), Matthias Schmitz, (unknown), Saima Zafar, Neelam Younas, (unknown), Angela da Silva Correia, (unknown), Inga Zerr	2
2	Klinik und Diagnostik humaner spongiformer Enzephalopathien: ein Update 2024 ·Der Nervenarzt ·Péter Hermann, Stefan Goebel, Inga Zerr	0
3	Comparative interactome mapping of Tau‐protein in classical and rapidly progressive Alzheimer's disease identifies subtype‐specific pathways 2024 ·Neuropathology and Applied Neurobiology ·(unknown), Neelam Younas, Muhammad Javed Iqbal, Isidró Ferrer, Inga Zerr	5
4	A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis 2024 ·Pathogens ·Ioannis Paspaltsis, Ειrini Kanata, (unknown), (unknown), Matthias Schmitz, Inga Zerr, Dimitra Dafou, Konstantinos Xanthopoulos, Theodoros Sklaviadis	1
5	SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia 2024 ·Biomedicines ·(unknown), (unknown), Ειrini Kanata, Kostas Vekrellis, Vasilios C. Constantinides, George P. Paraskevas, (unknown), Matthias Schmitz, Inga Zerr, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Dimitra Dafou	5
6	Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration 2024 ·Biomolecules ·Saima Zafar, (unknown), Matthias Schmitz, Inga Zerr	16
7	Synthesis, structural characterization and study of antioxidant and anti-PrPSc properties of flavonoids and their rhenium(I)–tricarbonyl complexes 2023 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown), (unknown), Konstantinos Xanthopoulos, (unknown), Susana Correia, (unknown), Katrin Thüne, Antonios G. Hatzidimitriou, Inga Zerr, Matthias Schmitz, Theodoros Sklaviadis, Dimitra Hadjipavlou‐Litina, Dionysia Papagiannopoulou	3
8	Application of real-time quaking-induced conversion in Creutzfeldt–Jakob disease surveillance 2023 ·Journal of Neurology ·Péter Hermann, Matthias Schmitz, Maria Cramm, Stefan Goebel, (unknown), (unknown), Walter Schulz‐Schaeffer, Christine Stadelmann, Jakob Matschke, Markus Glatzel, Inga Zerr	5
9	Genetic Variants Associated with the Age of Onset Identified by Whole-Exome Sequencing in Fatal Familial Insomnia 2023 ·Cells ·Katrin Thüne, Matthias Schmitz, (unknown), Orr Shomroni, Stefan Göbel, (unknown), Neelam Younas, Saima Zafar, Péter Hermann, Inga Zerr	1
10	Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease 2022 ·Cell and Tissue Research ·Susana Correia, Matthias Schmitz, André Fischer, Péter Hermann, Inga Zerr	3
11	SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson’s Disease Patients 2022 ·International Journal of Molecular Sciences ·Saima Zafar, (unknown), Neelam Younas, Mohsin Shafiq, Matthias Schmitz, Isabel Wurster, Kathrin Brockmann, Thomas Gasser, Inga Zerr	4
12	Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease 2022 ·Molecular Neurobiology ·Matthias Schmitz, (unknown), Juan Carlos Espinosa, Natalia Fernández‐Borges, Anna Villar‐Piqué, Franc Llorens, Daniela Varges, Fabian Maass, Juan María Torres, Péter Hermann, Inga Zerr	8
13	Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo 2021 ·Movement Disorders ·(unknown), Matthias Schmitz, (unknown), Angela da Silva Correia, Susana Correia, Franc Llorens, (unknown), Wiebke Möbius, (unknown), Saima Zafar, Erik Stoops, Christopher J. Silva, André Fischer, Tiago F. Outeiro, Inga Zerr	17
14	Altered mRNA and Protein Expression of Monocarboxylate Transporter MCT1 in the Cerebral Cortex and Cerebellum of Prion Protein Knockout Mice 2021 ·International Journal of Molecular Sciences ·Sanja Ramljak, Matthias Schmitz, Cendrine Repond, Inga Zerr, Luc Pellerin	6
15	Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays 2020 ·Translational Neurodegeneration ·Niccolò Candelise, Matthias Schmitz, Katrin Thüne, Maria Cramm, Alberto Rábano, Saima Zafar, Erik Stoops, Hugo Vanderstichele, Anna Villar‐Piqué, Franc Llorens, Inga Zerr	57
16	Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development 2019 ·Proceedings of the National Academy of Sciences ·Sonia M. Vallabh, Chloe K. Nobuhara, Franc Llorens, Inga Zerr, Piero Parchi, Sabina Capellari, Eric Kuhn, Jacob A. Klickstein, Jiri Safar, Flávia C. Nery, Kathryn J. Swoboda, Michael D. Geschwind, Henrik Zetterberg, Steven E. Arnold, Eric Vallabh Minikel, Stuart L. Schreiber	27
17	Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency 2019 ·Molecular Neurobiology ·Matthias Schmitz, Niccolò Candelise, Ειrini Kanata, Franc Llorens, Katrin Thüne, Anna Villar‐Piqué, Susana Correia, Dimitra Dafou, Theodoros Sklaviadis, Dietmar Appelhans, Inga Zerr	14
18	Plasma YKL-40 in the spectrum of neurodegenerative dementia 2019 ·Journal of Neuroinflammation ·Anna Villar‐Piqué, Matthias Schmitz, Péter Hermann, Stefan Goebel, (unknown), Daniela Varges, Isidró Ferrer, J. Riggert, Franc Llorens, Inga Zerr	51
19	CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·Kaj Blennow, Daniela Díaz‐Lucena, Henrik Zetterberg, Anna Villar‐Piqué, André Karch, Enríc Vidal, Péter Hermann, Matthias Schmitz, (unknown), Inga Zerr, Franc Llorens	52
20	Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy 2018 ·Molecular Neurobiology ·Matthias Schmitz, Anna Villar‐Piqué, Franc Llorens, Karin Gmitterová, Péter Hermann, Daniela Varges, Saima Zafar, Paul Lingor, Hugo Vanderstichele, (unknown), Erik Stoops, John Q. Trojanowski, Virginia M.‐Y. Lee, Inga Zerr	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact